brucellosis disease. Brucellosis due to Brucella melitensis
Conditions
Interventions
Intervention 1: Intervention group: patients with brucellosis who is diagnosed by clinical finding and lab data . patients with compatible sign and symptom
if have a wright test equal or more than 1/160 is allocated in case group. This group receive levofloxacine 750 mg daily and doxycycline 100 mg twice daily . 1 and 2 month after treatment CBC, ESR,CRP
if have a wright test equal or more than 1/160 is allocated in case group and this group will be treated by doxtcycline and rifampine for 2 month. Dosage of doxycycline is 100 mg BD and rifampine
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients older than 18 years with brucellosis
Exclusion criteria
Exclusion criteria: pregnancy history of sensitivity to drug meningitis endocarditis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: by thermometer and patient report.;Body pain. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: patient report.;DIAPHORESIS. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: patient report.;Diaphoresis. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: patient report.;ESR. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: by laborator.;CRP. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: BY laboratoary.;WRIGHT. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: agglutination test.;2ME. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: agglutination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehzad Mohsenpour
Sanandaj University of Medical Sciences
Outcome results
None listed